BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sonderup MW, Dusheiko G, Desalegn H, Lemoine M, Tzeuton C, Taylor-Robinson SD, Spearman CW. Hepatitis B in sub-Saharan Africa-How many patients need therapy? J Viral Hepat 2020;27:560-7. [PMID: 31800145 DOI: 10.1111/jvh.13247] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Amponsah-Dacosta E. Hepatitis B virus infection and hepatocellular carcinoma in sub-Saharan Africa: Implications for elimination of viral hepatitis by 2030? World J Gastroenterol 2021; 27(36): 6025-6038 [PMID: 34629817 DOI: 10.3748/wjg.v27.i36.6025] [Reference Citation Analysis]
2 Schmit N, Nayagam S, Thursz MR, Hallett TB. The global burden of chronic hepatitis B virus infection: comparison of country-level prevalence estimates from four research groups. Int J Epidemiol. 2021;50:560-569. [PMID: 33367672 DOI: 10.1093/ije/dyaa253] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Kazmi SK, Khan FMA, Natoli V, Hunain R, Islam Z, Costa ACDS, Ahmad S, Essar MY. Viral hepatitis amidst COVID-19 in Africa: Implications and recommendations. J Med Virol 2022;94:7-10. [PMID: 34506635 DOI: 10.1002/jmv.27330] [Reference Citation Analysis]